Get access to our best features
Get Started
SubscribeLogin
Get access to our best features
Get Started
Published

Levofloxacin: A new shield against drug-resistant TB

Summary by theindiansun.com.au
The fight against drug-resistant tuberculosis (TB) has taken a significant leap forward with recent findings from a clinical trial involving the oral antibiotic levofloxacin. Conducted by researchers at the University of Sydney’s Woolcock Institute of Medical Research in collaboration with the Vietnam Tuberculosis Program, the trial has demonstrated the efficacy and safety of levofloxacin in reducing the risk of developing multidrug-resistant TB…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Sydney, Australia

Sydney, Australia

Saarbrücken

Saarbrücken

Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2025 Snapwise Inc
News
For You
Search
BlindspotLocal